Revenue: The sum of all revenue fields included for a company's operating activities.
Recursion Pharmaceuticals, Inc. (RXRX) had Revenue of $5.17M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
$5.17M |
$-162.25M |
|
$14.69M |
|
$-9.51M |
|
$177.38M |
|
$-172.20M |
|
$9.95M |
|
$-162.25M |
|
$-162.25M |
|
$-162.25M |
|
$-162.25M |
|
$-162.25M |
|
$-162.25M |
|
$-172.20M |
|
$-151.16M |
|
446.99M |
|
446.99M |
|
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$714.11M |
|
$111.71M |
|
$685.42M |
|
$1.40B |
|
$155.10M |
|
$11.90M |
|
$197.47M |
|
$352.58M |
|
$1.05B |
|
$562.56M |
|
$1.05B |
|
491.80M |
|
| Cash Flow Statement Financials | |
$-325.74M |
|
$-15.63M |
|
$389.53M |
|
$603.02M |
|
$667.14M |
|
$64.12M |
|
$87.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.60 |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
-183.81% |
|
-3327.57% |
|
-3327.57% |
|
-- |
|
-3135.27% |
|
-3135.32% |
|
$-330.96M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.24 |
|
381.04 |
|
-15.50% |
|
-28.84% |
|
-11.59% |
|
-15.32% |
|
$2.13 |
|
$-0.74 |
|
$-0.73 |
|